The seed round was backed by Episode 1 Ventures, MMC Ventures and Seedcamp to support team expansion and product development.
"We are excited to be partnering with leading venture capital firms to create the placing experience the reinsurance community has dreamt of for decades. Paired with Riskbook's win-win-win philosophy, this new funding cements our role as a trusted independent provider to cedents, brokers and reinsurers alike."
Beringea led the seed investment round to support platform development and commercial expansion.
"We are delighted that Beringea have joined us on our journey to help our customers maximise their social value. Their investment will allow us to develop our ground-breaking platform to the next level of growth and success, opening up new markets and new opportunities."
The Boston investor backs the clinical stage biotechnology firm to advance its immune-resetting therapies.
"We have two clinical stage drug product candidates, '1805 and '1104, that have demonstrated impressive efficacy and safety data in phase 2a clinical studies on Rheumatoid Arthritis and Allergic Disease respectively and we are delighted to have Morningside as a partner to advance our programs,"
The funding round was backed by prominent family offices and angel investors including Lord Jacob Rothschild and Reuben Brothers Capital.
"We are delighted to have closed our series A funding round with support from such prominent names in the investment world. The home buying process has had little impact from technology and innovation, which has transformed our experiences in other areas of our life from shopping to food ordering. While home buying is naturally a more complex process, it can still be dramatically improved and optimised. Our e-Homebuying platform will make homebuying a simpler and more streamlined process for all parties involved, saving money and time."